Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,215,367
+$1,656,927 QoQ
Shares Held
42,278
+167.7% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#168
of 421 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $43,412,538 across 29 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
121,151 | $8,705,910 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
45,360 | $7,644,974 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,855 | $5,339,734 | |
| 4 | VTRS |
Viatris Inc
|
197,717 | $3,139,745 | |
| 5 | HLN |
Haleon plc
|
263,202 | $2,455,674 | |
| 6 | HROW |
Harrow, Inc.
|
56,414 | $2,395,902 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
143,998 | $2,308,287 | |
| 8 | ALKS |
Alkermes plc.
This page
|
42,278 | $2,215,367 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,215,367 | 42,278 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $558,440 | 15,793 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,028,740 | 36,767 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $921,900 | 30,730 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $916,063 | 32,019 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $642,635 | 19,462 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $528,091 | 18,362 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $468,636 | 16,743 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $418,954 | 17,384 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $417,148 | 15,410 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $780,159 | 28,124 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $668,878 | 23,880 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $487,153 | 15,564 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $408,050 | 14,475 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $350,194 | 13,402 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $286,873 | 12,847 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $22,997 | 772 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $182,959 | 6,954 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,885 | 511 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,604 | 279 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $6,767 | 276 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,155 | 276 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $20,648 | 1,035 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $121,118 | 6,240 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||